Governed Execution: Reimagining Clinical Trial Workflows in 30 Days
A structured 30-day onboarding process, Customize, Collaborate, Build, Launch, takes regulated clinical operational work from planning to full platform launch.
Resources
Blog
Writing on governed execution, oversight, and inspection-readiness for the teams running regulated clinical operations.
-
-
Traceable Operations: Designing a Validated Execution Environment
A Validated Execution Environment replaces retrospective folder cleanups with continuous oversight and a documented audit trail, built as work happens.
-
The Execution Layer for Clinical Trials
Cloud Concinnity is the execution layer between the systems of record clinical trial teams already trust, standardizing the work that happens around them.
-
Spotlight on Immunology: One Protocol, Many Diagnoses
Immune-mediated conditions range from common to rare, each with its own diagnostic criteria, and a single trial's oversight has to hold that variety to one standard.
-
Spotlight on Rare Diseases: How Data Diversity Drives Innovation in Rare Disease Trials
Rare disease trials pair small patient populations with wide geographic reach, which leaves little room for coordination to fail.
-
Spotlight on Neurology: When Endpoints Depend on the Rater
In neurology and psychiatry trials, the endpoint is a clinical judgment applied to a scale, which makes rater consistency its own oversight problem.
-
Spotlight on Oncology: Coordinating Independent Response Review
Assessing whether a tumor has responded to treatment is often done by an independent panel, separate from the site. Coordinating that panel is its own discipline.
-
Spotlight on Breast Cancer: Managing Regulatory Complexity
Breast cancer trial programs tend to run long, span regions, and amend often, which puts sustained pressure on the coordination behind compliance.
-
Spotlight on Cardiology: Continuity Across Long Trials
Cardiology trials often run for years and combine more than one kind of intervention, which puts a premium on oversight that outlasts any single committee member.
-
Personalized Therapies Complicate Trial Oversight
When eligibility and dosing turn on a patient's genetic or biomarker profile, oversight committees are making per-patient calls, not population ones.
-
Bridging Expertise: How Sponsor-CRO Collaboration Is Shaping the Future of Clinical Trials
Sponsors are dividing trial work with CROs in more ways than one model allows. What doesn't change with the model is who owns the oversight.
-
Improving Safety Reviews Through Centralized Workflow
Safety review delay is rarely the medical judgment itself. It's the time spent pulling data from several separate systems before judgment can start.
-
The Operational Risk Clinical Trial Risk Plans Miss
Risk plans are thorough about protocol, safety, and data risk. They rarely name the risk that the documented process wasn't actually followed.
-
Trial Technology Doesn't Reduce Complexity, It Relocates It
Every specialized system a trial adopts solves one problem well and adds one more thing that has to be coordinated across the team.
-
Access Governance for Blinded Trial Data
The core data protection risk for a data safety monitoring board is not network security. It is who can see blinded data, and whether that is documented.